Citigroup’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,756
| Closed | -$13.6K | – | 5000 |
|
|
2024
Q4 | $13.6K | Buy |
+7,756
| New | +$13.6K | ﹤0.01% | 4466 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5109 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5133 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5082 |
|
|
2018
Q1 | – | Hold |
0
| – | -$1K | – | 5018 |
|
|
2017
Q4 | – | Hold |
0
| – | -$1K | – | 4905 |
|
|
2017
Q3 | – | Hold |
0
| – | -$1K | – | 4622 |
|
|
2017
Q2 | – | Hold |
0
| – | -$1K | – | 4751 |
|
|
2017
Q1 | – | Sell |
-11
| Closed | -$75K | – | 4737 |
|
|
2016
Q4 | $75K | Buy |
11
+10
| +1,000% | +$68.2K | ﹤0.01% | 4011 |
|
|
2016
Q3 | $12K | Hold |
1
| – | – | ﹤0.01% | 4387 |
|
|
2016
Q2 | $15K | Buy |
+1
| New | +$15K | ﹤0.01% | 4327 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5236 |
|
|
2015
Q4 | – | Hold |
0
| – | -$3K | – | 5655 |
|
|
2015
Q3 | – | Hold |
0
| – | -$8K | – | 4821 |
|
|
2015
Q2 | – | Hold |
0
| – | -$1K | – | 4691 |
|
|
2015
Q1 | – | Hold |
0
| – | -$4K | – | 5359 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 5103 |
|
|
2014
Q3 | – | Hold |
0
| – | -$1K | – | 5595 |
|
|
2014
Q2 | – | Hold |
0
| – | -$1K | – | 5318 |
|
|
2014
Q1 | – | Hold |
0
| – | -$2K | – | 5343 |
|
|
2013
Q4 | – | Hold |
0
| – | -$3K | – | 5186 |
|
|
2013
Q3 | – | Hold |
0
| – | -$3K | – | 4890 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 4813 |
|